Validation of the angioedema control test (AECT) – a patient reported outcome instrument for assessing angioedema control

by admin | Nov 8, 2020

Recurrent angioedema (RA) is an important clinical problem in routine care and emergency medicine. As of recently, the only validated tools to specifically assess disease status in patients with RA were diary-type activity assessments and angioedema-related...

Development of the angioedema control test (AECT) – a patient reported outcome measure that assesses disease control in patients with recurrent angioedema

by admin | Oct 7, 2020

Background: Recurrent angioedema (AE) is an important clinical problem in the context of chronic urticaria (mast cell mediator–induced), ACE-inhibitor intake and hereditary angioedema (both bradykinin-mediated). To help patients obtain control of their recurrent AE is...

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

by mm-red | Jun 25, 2020

Purpose of review: The aim of this review is to highlight the most important, clinically relevant patient-reported outcome (PRO) measures for chronic spontaneous urticaria and recurrent angioedema. Recent findings: The use of PROs becomes increasingly important in...

Clinical measures of chronic urticaria

by mm-red | Jun 23, 2020

How to control recurrent angioedema using monoclonal antibody therapies?

by mm-red | Jun 17, 2020